-
1 month ago | 
medscape.co.uk | Kevin Fernando |Nida Khan
View from the Ground, by Dr Kevin Fernando and Nida KhanAs a GP, I see daily how cardiovascular, renal, and metabolic (CVRM) conditions are interconnected.
-
Jan 13, 2025 | 
medscape.com | Kevin Fernando
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. My Alerts You have already selected for My Alerts Add Other Topics Click the topic below to receive emails when new articles are available. Add You've successfully added to your alerts. You will receive email when new content is published.
-
Nov 18, 2024 | 
mdedge.com | Kevin Fernando
This transcript has been edited for clarity. In this podcast, I’m going to talk about unexplained high platelet counts, or thrombocytosis, and the risk for cancer in primary care. Let’s start with a typical case we all might see in primary care. Louisa is 47 years old and is the chief financial officer for a tech startup company. She presents to us in primary care feeling tired all the time — a very common presentation in primary care — with associated reduced appetite.
-
Nov 12, 2024 | 
medscape.com | Kevin Fernando
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. My Alerts You have already selected for My Alerts Add Other Topics Click the topic below to receive emails when new articles are available. Add You've successfully added to your alerts. You will receive email when new content is published.
-
Oct 24, 2024 | 
medscape.co.uk | Kevin Fernando
In this speaker session filmed at Guidelines Live2023, Dr Kevin Fernando talks about how to identify and manage metabolic dysfunction-associated steatotic liver disease (formerly nonalcoholic fatty liver disease) and metabolic dysfunction-associated steatohepatitis in primary care, including how to interpret liver blood tests.
-
Oct 11, 2024 | 
medscape.com | Kevin Fernando
This transcript has been edited for clarity. In this podcast, I'm going to give an update on SGLT2 inhibitors, which I reckon are the biggest therapeutic advance in my career to date. I've been prescribing SGLT2 inhibitors for over 10 years now in primary care, and during that time, prescribing indications of SGLT2 inhibitors have significantly expanded beyond their original use for glycemic management in type 2 diabetes, driven by a rapidly evolving and high-quality evidence base.
-
Oct 11, 2024 | 
medscape.co.uk | Kevin Fernando
The 2024 joint European Association for the Study of the Liver, European Association for the Study of Diabetes, and European Association for the Study of Obesity (EASL–EASD–EASO) clinical practice guideline for the diagnosis, treatment, and follow-up of individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) is an update to the multisociety nonalcoholic fatty liver disease guideline released in 2016.
-
Oct 4, 2024 | 
medscape.co.uk | Kevin Fernando
Guidelines presents Primary Care Hacks, a series of clinical aide-mémoires across a range of topics. Developed by Dr Kevin Fernando, Primary Care Hacks aim to provide a quick and easy resource for primary healthcare professionals and ultimately help improve patients' lives.
-
Sep 30, 2024 | 
mdedge.com | Kevin Fernando
FROM EASD 2024Further data from the FLOW study were presented during the 2024 congress of the European Association for the Study of Diabetes (EASD) in Madrid. The FLOW study was originally presented in May at the European Renal Association’s 2024 congress in Stockholm. It was the first dedicated kidney outcomes trial to examine a GLP-1 receptor agonist.
-
Sep 23, 2024 | 
medscape.com | Kevin Fernando
closePlease confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. My Alerts You have already selected for My Alerts Add Other Topics Click the topic below to receive emails when new articles are available. Add You've successfully added to your alerts. You will receive email when new content is published. Manage Email Alerts
